Sanofi in talks to sell 50% stake in consumer health business to US private equity firm

FRANCE 24 English

Visit our website: http://www.france24.com  Like us on Facebook: https://www.facebook.com/FRANCE24.English  Follow us on Twitter: https://twitter.com/France24_en

Transcript

00:00Could one of France's most well-known over-the-counter drugs soon come under American control?

00:06Doliprane's yellow boxes are omnipresent in French pharmacies and its potential sale has got some worried.

00:30Sanofi, the parent company of Opéra, which manufactures Doliprane,

00:36is currently in talks to sell a controlling 50% stake of the business to an American private equity firm,

00:43CD&R.

00:45Reports say the deal could be worth 15 billion euros.

00:48Here in Lisieux, one of two sites where Doliprane is manufactured, some employees say they're worried for the future.

01:00Unions, too, are concerned.

01:11Sanofi says it's a strategic decision to refocus its business on research into new vaccines and medicines.

01:18A big concern is whether CD&R would move production of Doliprane out of France.

01:30Talks between Sanofi and CD&R are set to continue for the next few weeks before a sale is agreed.

Category

Transcript

Recommended